RT @sarahhudsonuk: Next William Abraham talked about what has been learnt from clinical trials, focusing on BeAT-HF which was an RCT that s…
RT @sarahhudsonuk: Next William Abraham talked about what has been learnt from clinical trials, focusing on BeAT-HF which was an RCT that s…
RT @sarahhudsonuk: Next William Abraham talked about what has been learnt from clinical trials, focusing on BeAT-HF which was an RCT that s…
Next William Abraham talked about what has been learnt from clinical trials, focusing on BeAT-HF which was an RCT that showed BAT significantly improved exercise capacity, QoL, NYHA class and NTproBNP, and was safe Paper: https://t.co/Gp8x0D1ugB #ESCCon
RT @drjohnm: I am no fan of insurance companies adjudicating med decisions But this device was approved w shoddy evidence Regulatory tr…
I am no fan of insurance companies adjudicating med decisions But this device was approved w shoddy evidence Regulatory trial did NOT measure clinical outcomes Measured mostly QOL and was NOT BLINDED. https://t.co/ffANyIscQa Cc @kaulcsmc @BradleyTh
RT @tripdatabase: New2Trip: Baroreflex Activation Therapy in Patients w/ Heart Failure w/ Reduced Ejection Fraction https://t.co/bU8YWtxAxx
New2Trip: Baroreflex Activation Therapy in Patients w/ Heart Failure w/ Reduced Ejection Fraction https://t.co/bU8YWtxAxx
New2Trip: Baroreflex Activation Therapy in Patients w/ Heart Failure w/ Reduced Ejection Fraction https://t.co/bU8YWtxAxx
New2Trip: Baroreflex Activation Therapy in Patients w/ Heart Failure w/ Reduced Ejection Fraction https://t.co/bU8YWtxAxx
RT @tripdatabase: New2Trip: Baroreflex Activation Therapy in Patients w/ Heart Failure w/ Reduced Ejection Fraction https://t.co/bU8YWtxAxx
New2Trip: Baroreflex Activation Therapy in Patients w/ Heart Failure w/ Reduced Ejection Fraction https://t.co/bU8YWtxAxx
RT @JACCJournals: Can carotid baroreflex therapy help in #HFrEF? Learn more in #JACC: https://t.co/1lwV8UvfNV https://t.co/w09RBTe3Jw
RT @JACCJournals: Can carotid baroreflex therapy help in #HFrEF? Learn more in #JACC: https://t.co/1lwV8UvfNV https://t.co/w09RBTe3Jw
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction | JACC: Journal of the American College of Cardiology https://t.co/qqpl906CZh
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction https://t.co/CrNJvE0AXa https://t.co/Cq6V0dErC1
RT @JACCJournals: Can carotid baroreflex therapy help in #HFrEF? Learn more in #JACC: https://t.co/1lwV8UvfNV https://t.co/w09RBTe3Jw
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JACCJournals: Can carotid baroreflex therapy help in #HFrEF? Learn more in #JACC: https://t.co/1lwV8UvfNV https://t.co/w09RBTe3Jw
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JACCJournals: Can carotid baroreflex therapy help in #HFrEF? Learn more in #JACC: https://t.co/1lwV8UvfNV https://t.co/w09RBTe3Jw
Can carotid baroreflex therapy help in #HFrEF? Learn more in #JACC: https://t.co/1lwV8UvfNV https://t.co/w09RBTe3Jw
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
RT @JuliaSellerm: Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical ma…
Baroreflex activation therapy in HFrEF @JACCJournals 👥 NYHA III or II (recent history of III) EF <35% Stable medical management No class I indication CRT ✅ QOL, exercise capacity and NT-proBNP 📁 https://t.co/Cim8r9qy9d https://t.co/Zm7wdqZMbI
RT @HanCardiomd: Afferent baroreflex activation through electrical stimulation of the carotid sinus nerve . BAT was safe and significantly…
RT @JBauersachsMD: Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in P…
RT @JBauersachsMD: Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in P…
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction | JACC: Journal of the American College of Cardiology https://t.co/qqpl906CZh
RT @JBauersachsMD: Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in P…
RT @JBauersachsMD: Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in P…
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction https://t.co/6X7fMuEsJ3
@KardiologieHH
RT @JBauersachsMD: Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in P…
RT @JBauersachsMD: Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in P…
Just published: BeAT-HF demonstrates improved QoL, exercise capacity and NP levels by Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction | JACC: https://t.co/CwRGscAkQW
Afferent baroreflex activation through electrical stimulation of the carotid sinus nerve . BAT was safe and significantly improved QOL, exercise capacity, and NT-proBNP. (Baroreflex Activation Therapy for Heart Failure BeAT-HF https://t.co/4srlExSJSd @JACC
HFrEFに対する圧受容器反射賦活化療法 圧受容器反射反射を賦活化すると強力に交感神経活動を低下させることを利用した新規治療法。 Baroreflex研究に携わってきたので、この結果だけで一晩話せる。 https://t.co/13k0cvyxv0